Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A4071 Fluorouracil (Adrucil)3 CitationTarget: Thymidylate SynthaseSummary: Antitumor agent;inhibitor of thymidylate synthase
-
A1926 CA 0742 CitationTarget: CathepsinsSummary: Cathepsin B inhibitor
-
A4006 MK-07521 CitationSummary: γ-secretase inhibitor
-
A4018 YO-01027 (Dibenzazepine, DBZ)1 CitationSummary: γ-secretase inhibitor
-
A4056 AT13387Target: HSP90Summary: Hsp90 inhibitor
-
A4061 IPI-504 (Retaspimycin hydrochloride)3 CitationTarget: HSP90Summary: Hsp90 inhibitor,novel, potent,selective
-
A4064 NVP-BEP800Target: HSP90Summary: Oral Hsp90β inhibitor, novel, fully synthetic
-
A8177 PAC-11 CitationTarget: CaspasesSummary: Procaspase-3 activator
-
B7393 GeduninTarget: HSP90Summary: naturally occurring Hsp90 inhibitor
-
B4920 EC 144Target: HSP90Summary: High affinity, potent and selective Hsp90 inhibitor